Angio adding exec position - The Business Review (Albany):

http://acertivetravel.com/cdn/bc/kelowna/real-estate.htm
AngioDynamics (NYSE: ANGO) said Tuesday that it has hirerMichael Sharp, 59, to oversee the company’d regulatory, quality control and clinical departments. Shar p joins the company at the start of a procesws toreplace co-founder Eamonn Hobbs, who will leave his role as presidentf and CEO and become vice chairman of the AngioDynamics announced the transition last The company has not announced a timeline for the only saying that it has hired an executive searc h firm to help find candidatezs for Hobbs’ job.
Sharp, meanwhile, comexs to AngioDynamics from , a privateluy held medical device company in The company focuses onorthopedic products, and Shar had been its senior vice president for regulatory and clinical All told, Sharp has spent 30 years at medical device and he also served as chief regulatoryh officer at ’s cancer institute in Atlanta. He has degrees from the and . At AngioDynamics, Sharp will reporrt to William Appling, senior vice presideny for researchand development. Sharp’s salary has not been AngioDynamics stock closedat $11.05 a share on Dec. 8, up 82 centsa on the day.